Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy
about
Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodesEvaluating the impact of prescription drug monitoring program implementation: a scoping review.Geographic variation of chronic opioid use in fibromyalgia.Prescription drug monitoring program utilization in Kentucky community pharmacies.The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute PainPrescription monitoring programs and emergency department visits involving opioids, 2004-2011.Collaboration or coercion? Partnering to divert prescription opioid medications.Seeking prescription opioids from physicians for nonmedical use among people who inject drugs in a Canadian setting.Effect of a "pill mill" law on opioid prescribing and utilization: The case of TexasPrescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.High-Risk Prescribing to Medicaid Enrollees Receiving Opioid Analgesics: Individual- and County-Level Factors.Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort studyPhysicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative StudyAssociation Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review
P2860
Q33777521-C275A0C7-EB00-44AB-85A5-4E602496017FQ33816280-A5BB18BC-BCBE-4D61-812D-8F0ACB1E7897Q35136682-F92BCD26-FC9B-4FA1-87E3-9BAFDB841E0CQ35788530-C7AC7508-65BF-4C42-8C0C-3526B83F072BQ35804625-9A7B0241-1F6F-40AE-B992-14ADE071EEBEQ37015810-5E9E06CE-9AA6-4C86-AB9A-604F6C59A2CEQ37067857-600BB560-F237-44E4-993B-C8B312090271Q37097438-80FF5B7F-5721-42AB-8FCD-D81E8DFC02B0Q37157553-97E53793-3E60-4FFA-BCE4-FDEBECC0B829Q37679687-64CBD042-13E1-41FF-B366-E883B0434AE6Q42130862-F95C412F-B091-4899-B867-388E726C670DQ47206411-C53846AF-2D2E-4E0A-8C1F-BBD4C97EED15Q50061813-92E95E0D-A7EA-4D61-AE47-E4D264E87B35Q56514344-77BC205E-FF7C-4BAD-BECC-A7AEA41023E5Q57210258-DA2476A3-62C6-4E93-9A73-5EB2B28E4C3DQ58231671-AA9746F9-A179-451E-839B-1BF1CED964E3
P2860
Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prescription opioid usage and ...... ug monitoring program efficacy
@en
Prescription opioid usage and ...... g monitoring program efficacy.
@nl
type
label
Prescription opioid usage and ...... ug monitoring program efficacy
@en
Prescription opioid usage and ...... g monitoring program efficacy.
@nl
prefLabel
Prescription opioid usage and ...... ug monitoring program efficacy
@en
Prescription opioid usage and ...... g monitoring program efficacy.
@nl
P2093
P2860
P356
P1476
Prescription opioid usage and ...... ug monitoring program efficacy
@en
P2093
Adam J Atherly
Christopher R Flowers
Pareen J Shenoy
Richard M Reisman
P2860
P356
10.4137/SART.S2345
P577
2009-05-01T00:00:00Z